Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MCRB

Seres Therapeutics

$9.66

-0.68 (-6.58%)

06:06
11/14/17
11/14
06:06
11/14/17
06:06
Hot Stocks
Seres Therapeutics, MD Anderson and Parker Institute announce collaboration »

Seres Therapeutics, The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 29

    Nov

Over a week ago
MCRB

Seres Therapeutics

$9.58

-0.4 (-4.01%)

07:05
11/08/17
11/08
07:05
11/08/17
07:05
Earnings
Seres Therapeutics reports Q3 EPS (17c), consensus (41c) »

Reports Q3 revenue $23M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 28

    Nov

MCRB

Seres Therapeutics

$9.98

0.01 (0.10%)

07:10
11/07/17
11/07
07:10
11/07/17
07:10
Hot Stocks
Seres Therapeutics awarded grand from CARB-X to support development of SER-155 »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 28

    Nov

Over a month ago
MCRB

Seres Therapeutics

$10.87

-0.1 (-0.91%)

16:19
10/12/17
10/12
16:19
10/12/17
16:19
Initiation
Seres Therapeutics initiated at Oppenheimer »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$12.00

-0.41 (-3.30%)

07:03
10/06/17
10/06
07:03
10/06/17
07:03
Initiation
Seres Therapeutics initiated at Seaport Global »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$16.04

-0.46 (-2.79%)

07:35
10/02/17
10/02
07:35
10/02/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Seres Therapeutics »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$16.04

-0.46 (-2.79%)

07:06
10/02/17
10/02
07:06
10/02/17
07:06
Hot Stocks
Seres: SER-287 resulted in dose-dependent benefit in Phase 1b study »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$16.04

-0.46 (-2.79%)

06:58
10/02/17
10/02
06:58
10/02/17
06:58
Hot Stocks
Breaking Hot Stocks news story on Seres Therapeutics »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MCRB

Seres Therapeutics

$13.32

-0.15 (-1.11%)

07:14
08/03/17
08/03
07:14
08/03/17
07:14
Earnings
Seres Therapeutics reports Q2 EPS (69c), consensus (64c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

MCRB

Seres Therapeutics

$11.14

0.11 (1.00%)

, AMGN

Amgen

$171.43

-0.29 (-0.17%)

07:06
07/10/17
07/10
07:06
07/10/17
07:06
Hot Stocks
Seres Therapeutics names former Amgen CMO Willard Dere to board »

Seres Therapeutics (MCRB)…

MCRB

Seres Therapeutics

$11.14

0.11 (1.00%)

AMGN

Amgen

$171.43

-0.29 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 19

    Jul

  • 25

    Jul

  • 14

    Aug

  • 14

    Sep

  • 03

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.